Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1)

Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Suppliers list
Company Name: Changsha Jing Kang New Material Technology Co., Ltd.  
Tel: 0731-85118349 18874718518
Email: 877634463@qq.com
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Tunchem Pharm (Shanghai)Tech Co., Ltd.  
Tel: 13127540771
Email: sales@tunchem.com
Company Name: BOC Sciences  
Tel: +1-631-485-4226
Email: inquiry@bocsci.com
Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Basic information
Product Name:Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1)
Synonyms:Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1);Mevalonate (lithium salt);Lithium 3,5-dihydroxy-3-methylpentanoate
CAS:2618458-93-6
MF:C6H13LiO4
MW:156.11
EINECS:
Product Categories:
Mol File:2618458-93-6.mol
Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Structure
Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Chemical Properties
solubility DMSO: Soluble
form A solid
color White to off-white
Safety Information
MSDS Information
Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Usage And Synthesis
DescriptionMevalonate is an intermediate in the mevalonate pathway of cholesterol synthesis.1 It inhibits cell death induced by the HMG-CoA reductase inhibitor simvastatin in C2C12 myoblasts when used at concentrations ranging from 80 to 110 μM.2 Mevalonate (500 μM) reverses decreases in proliferation induced by the HMG-CoA reductase inhibitor lovastatin in several colon cancer cell lines, including RKO and SW480 cells.3 It increases lovastatin-induced decreases in the expression of the genes encoding Axin2, ectodermal-neural cortex 1 (ENC1), BCL2-like 1 (BCL2-L1), and cyclin D1 when used at a concentration of 500 μM. Mevalonate (50 μM) increases Rac1 protein levels, as well as increases Rac1 farnesylation induced by the arachidonic metabolite 15(S)-HETE in human dermal microvascular endothelial cells (HDMVECs).4
UsesMevalonic acid (MVA) lithium salt is a precursor substance of the mevalonate pathway, which is essential for cell growth and proliferation. Mevalonic acid lithium salt is effective in inhibiting Simvastatin (HY-17502)-induced decrease in C2C12 cell viability in vitro. Mevalonic acid lithium salt can be used in studies of myopathy and heart failure[1][2].
IC 50Human Endogenous Metabolite
References1. Yazawa, H., Zimmermann, B., Asami, Y., et al. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells J. Periodontol. 76(2),295-302(2005).
2. Moschetti, A., Dagda, R.K., and Ryan, R.O. Coenzyme Q nanodisks counteract the effect of statins on C2C12 myotubes Nanomedicine 37,102439(2021).
3. Gong, L., Xiao, Y., Xia, F., et al. The mevalonate coordinates energy input and cell proliferation Cell Death Dis. 10(4),327(2019).
4. Singh, N.K., Kundumani-Sridharan, V., and Rao, G.N. 12/15-Lipoxygenase gene knockout severely impairs ischemia-induced angiogenesis due to lack of Rac1 farnesylation Blood 118(20),5701-5712(2011).
Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1) Preparation Products And Raw materials
Tag:Pentanoic acid, 3,5-dihydroxy-3-methyl-, lithium salt (1:1)(2618458-93-6) Related Product Information
MONOSIALOGANGLIOSIDE GM3 coenzyme A n-valeryl derivative (C5:0), lithium salt N-HEXADECANOYL COENZYME A LITHIUM SALT Calcitriol Rapamycin Nicotinamide